BioCardia, Inc. (BCDA)

BioCardia Statistics

Total Valuation

BioCardia has a market cap or net worth of $6.56 million. The enterprise value is $8.67 million.

Market Cap	6.56M
Enterprise Value	8.67M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BioCardia has 5.80 million shares outstanding. The number of shares has increased by 163.54% in one year.

Current Share Class	5.80M
Shares Outstanding	5.80M
Shares Change (YoY)	+163.54%
Shares Change (QoQ)	+9.15%
Owned by Insiders (%)	23.47%
Owned by Institutions (%)	5.25%
Float	4.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.33

Current Ratio	0.33
Quick Ratio	0.27
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-222.28%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	570.12%
Revenue Per Employee	n/a
Profits Per Employee	-$439,700
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.86% in the last 52 weeks. The beta is 0.84, so BioCardia's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-59.86%
50-Day Moving Average	2.03
200-Day Moving Average	2.22
Relative Strength Index (RSI)	21.43
Average Volume (20 Days)	956,597

Short Selling Information

The latest short interest is 209,414, so 3.61% of the outstanding shares have been sold short.

Short Interest	209,414
Short Previous Month	372,812
Short % of Shares Out	3.61%
Short % of Float	4.84%
Short Ratio (days to cover)	0.38

Income Statement

Revenue	n/a
Gross Profit	-5.24M
Operating Income	-8.85M
Pretax Income	n/a
Net Income	-8.79M
EBITDA	-8.81M
EBIT	-8.85M
Earnings Per Share (EPS)	-$2.05

Balance Sheet

The company has $980,000 in cash and $745,000 in debt, giving a net cash position of $235,000 or $0.04 per share.

Cash & Cash Equivalents	980,000
Total Debt	745,000
Net Cash	235,000
Net Cash Per Share	$0.04
Equity (Book Value)	-1.89M
Book Value Per Share	-0.34
Working Capital	-2.44M

Cash Flow

In the last 12 months, operating cash flow was -$8.45 million and capital expenditures -$4,000, giving a free cash flow of -$8.46 million.

Operating Cash Flow	-8.45M
Capital Expenditures	-4,000
Free Cash Flow	-8.46M
FCF Per Share	-$1.46

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioCardia does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-163.54%
Shareholder Yield	-163.54%
Earnings Yield	-98.75%
FCF Yield	-94.95%

Analyst Forecast

The average price target for BioCardia is $25.00, which is 2,112.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.00
Price Target Difference	2,112.39%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 30, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	May 30, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

BioCardia has an Altman Z-Score of -124.44 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-124.44
Piotroski F-Score	1